Clinical Trials
8 trialsNCT04655807 2025-04-27
DUET
Janssen Research & Development, LLC
Phase 2 Withdrawn
NCT05599347 2025-04-04
AZITRATIM
Rambam Health Care Campus
Phase 2 Recruiting
NCT03944447 2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2 Unknown
NCT02538341 2021-11-23
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
University of Alabama at Birmingham
Phase 2 Completed
NCT01714726 2021-05-26
Evaluation of Efficacy and Safety of MEDI2070 in Patients With Active, Moderate-to-severe Crohn's Disease.
AstraZeneca
Phase 2 Completed
NCT02574637 2021-05-26
Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease
AstraZeneca
Phase 2 Terminated
NCT00584740 2015-03-31
Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
Novartis
Phase 2 Terminated
NCT00152841 2009-03-17
Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis
University Health Network, Toronto
Phase 2 Terminated